Skip to main
University-wide Navigation

Chemistry Researcher Develops Innovative Testing, Potential Remedies for Head Trauma, Alzheimer's

"I really just developed a love for the campus." Mark Lovell credits a history of collaboration at UK for driving his research for the past 30 years.

Antibiotics Could Be Promising Treatment for Form of Dementia

Researchers at UK's College of Medicine have found that a class of antibiotics could be promising treatment for a form of dementia. Results of their proof of concept study were recently published in the journal Human Molecular Genetics.

Conference Looks at Neurological Issues in the Pregnant Patient

The UK College of Medicine will host the 2019 Obstetrical Neurology Conference on Friday, Sept. 6, 2019 for faculty, providers and trainees in neurology, obstetrics, anesthesia and women's health interested in neurological issues in the pregnant patient.

Research Volunteers Drive Discoveries at Sanders-Brown Center on Aging

Thanks to volunteers, SBCoA has played a role in many landmark discoveries, including debunking the theories that aluminum or mercury cause Alzheimer's, identifying so-called "AD mimics", and proving that there are changes in the brain decades before there are outward symptoms of AD.

Preclinical Study of Therapeutic Strategy for Lafora Disease Shows Promise

A team of scientists have designed and tested a novel and promising therapeutic strategy for treating Lafora Disease (LD), a fatal form of childhood epilepsy.

UK Awarded $6 Million from NIH to Study Decision-Making Processes Behind Substance Use Disorders

Faculty from the Dept of Psychology in the College of Arts & Sciences and Behavioral Science in the College of Medicine have received two, five-year Research Project Grants from the NIH to study neurobehavioral processes involved in drug use disorders.

UK Neurologist Pens Editorial About Lack of Minority Representation in MS Drug Research

In an editorial published in CNS Spectrums, UK Neurologist Jay Avasarala, MD, PhD, takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).

UK Biochemist Recognized for Work in FUS-ALS

Researchers at the University of Kentucky have discovered new biological processes by which mutations in the FUS gene cause neurodegeneration in amyotrophic lateral sclerosis (ALS).

Gentry Receives National Award for Outstanding Mentorship

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, announced that University of Kentucky's Matthew Gentry has received the Landis Award for Outstanding Mentorship.

Register for Markesbery Symposium's Scientific, Community Sessions

The 8th Annual Sanders-Brown Center on Aging's Markesbery Symposium will take place Oct. 26-27.

Filter News